Spotlight: HELLDIVERS 2 x ODST Edition - Halo Waypoint
15 minutes ago • Google News
Halozyme Therapeutics Inc (HALO)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 8.75B
P/E Ratio
17.12
Revenue (TTM)
$ 1.18B
Volume
0
52W High
$ 74.94
52W Low
$ 42.01
Dividend Yield
0.00%
Beta
1.17
Technicals
50-Day MA
61.509
200-Day MA
57.0606
52 Week High
74.94
52 Week Low
42.01
About HALO
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
Employees
350
Headquarters
San Diego, CA
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.